Literature DB >> 17720996

Update of the drug resistance mutations in HIV-1: 2007.

Victoria A Johnson1, Françoise Brun-Vézinet, Bonaventura Clotet, Huldrych F Günthard, Daniel R Kuritzkes, Deenan Pillay, Jonathan M Schapiro, Douglas D Richman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17720996

Source DB:  PubMed          Journal:  Top HIV Med        ISSN： 1542-8826


× No keyword cloud information.
  52 in total

1.  Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapy.

Authors:  Binshan Shi; Christina Kitchen; Barbara Weiser; Douglas Mayers; Brian Foley; Kimdar Kemal; Kathryn Anastos; Marc Suchard; Monica Parker; Cheryl Brunner; Harold Burger
Journal:  Virology       Date:  2010-05-08       Impact factor: 3.616

Review 2.  2011 update of the drug resistance mutations in HIV-1.

Authors:  Victoria A Johnson; Vincent Calvez; Huldrych F Günthard; Roger Paredes; Deenan Pillay; Robert Shafer; Annemarie M Wensing; Douglas D Richman
Journal:  Top Antivir Med       Date:  2011-11

3.  Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication.

Authors:  Frauke Christ; Arnout Voet; Arnaud Marchand; Stefan Nicolet; Belete A Desimmie; Damien Marchand; Dorothée Bardiot; Nam Joo Van der Veken; Barbara Van Remoortel; Sergei V Strelkov; Marc De Maeyer; Patrick Chaltin; Zeger Debyser
Journal:  Nat Chem Biol       Date:  2010-05-16       Impact factor: 15.040

4.  Transmitted drug resistance and phylogenetic relationships among acute and early HIV-1-infected individuals in New York City.

Authors:  Delivette Castor; Andrea Low; Teresa Evering; Sharon Karmon; Brandi Davis; Amir Figueroa; Melissa LaMar; Donald Garmon; Saurabh Mehandru; Martin Markowitz
Journal:  J Acquir Immune Defic Syndr       Date:  2012-09-01       Impact factor: 3.731

5.  Sequence editing by Apolipoprotein B RNA-editing catalytic component [corrected] and epidemiological surveillance of transmitted HIV-1 drug resistance.

Authors:  Robert J Gifford; Soo-Yon Rhee; Nicolas Eriksson; Tommy F Liu; Mark Kiuchi; Amar K Das; Robert W Shafer
Journal:  AIDS       Date:  2008-03-30       Impact factor: 4.177

6.  Virologic response to lopinavir-ritonavir-based antiretroviral regimens in a multicenter international clinical cohort: comparison of genotypic interpretation scores.

Authors:  Philip Grant; Eric C Wong; Richard Rode; Robert Shafer; Andrea De Luca; Jeffrey Nadler; Trevor Hawkins; Calvin Cohen; Robert Harrington; Dale Kempf; Andrew Zolopa
Journal:  Antimicrob Agents Chemother       Date:  2008-08-18       Impact factor: 5.191

7.  Mutations in multiple domains of Gag drive the emergence of in vitro resistance to the phosphonate-containing HIV-1 protease inhibitor GS-8374.

Authors:  Kirsten M Stray; Christian Callebaut; Bärbel Glass; Luong Tsai; Lianhong Xu; Barbara Müller; Hans-Georg Kräusslich; Tomas Cihlar
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

8.  Prevalence of drug-resistant HIV-1 in rural areas of Hubei province in the People's Republic of China.

Authors:  Minqi Luo; Huan Liu; Ke Zhuang; Li Liu; Bo Su; Rongrong Yang; Po Tien; Linqi Zhang; Xien Gui; Zhiwei Chen
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

9.  HIV-1 reverse transcriptase connection subdomain mutations reduce template RNA degradation and enhance AZT excision.

Authors:  Krista A Delviks-Frankenberry; Galina N Nikolenko; Paul L Boyer; Stephen H Hughes; John M Coffin; Abhay Jere; Vinay K Pathak
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-30       Impact factor: 11.205

10.  Distinct resistance mutation and polymorphism acquisition in HIV-1 protease of subtypes B and F1 from children and adult patients under virological failure.

Authors:  Ana T Dumans; Cláudia C Barreto; André F Santos; Mônica Arruda; Thatiana M Sousa; Elizabeth S Machado; Ester C Sabino; Rodrigo M Brindeiro; Amílcar Tanuri; Alberto J Duarte; Marcelo A Soares
Journal:  Infect Genet Evol       Date:  2008-10-17       Impact factor: 3.342
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.